PMID- 38337615 OWN - NLM STAT- MEDLINE DCOM- 20240214 LR - 20240214 IS - 2072-6643 (Electronic) IS - 2072-6643 (Linking) VI - 16 IP - 3 DP - 2024 Jan 23 TI - Diet-Induced Severe Hyperhomocysteinemia Promotes Atherosclerosis Progression and Dysregulates the Plasma Metabolome in Apolipoprotein-E-Deficient Mice. LID - 10.3390/nu16030330 [doi] LID - 330 AB - Atherosclerosis and resulting cardiovascular disease are the leading causes of death in the US. Hyperhomocysteinemia (HHcy), or the accumulation of the intermediate amino acid homocysteine, is an independent risk factor for atherosclerosis, but the intricate biological processes mediating this effect remain elusive. Several factors regulate homocysteine levels, including the activity of several enzymes and adequate levels of their coenzymes, including pyridoxal phosphate (vitamin B6), folate (vitamin B9), and methylcobalamin (vitamin B12). To better understand the biological influence of HHcy on the development and progression of atherosclerosis, apolipoprotein-E-deficient (apoE(-/-) mice), a model for human atherosclerosis, were fed a hyperhomocysteinemic diet (low in methyl donors and B vitamins) (HHD) or a control diet (CD). After eight weeks, the plasma, aorta, and liver were collected to quantify methylation metabolites, while plasma was also used for a broad targeted metabolomic analysis. Aortic plaque burden in the brachiocephalic artery (BCA) was quantified via 14T magnetic resonance imaging (MRI). A severe accumulation of plasma and hepatic homocysteine and an increased BCA plaque burden were observed, thus confirming the atherogenic effect of the HHD. Moreover, a decreased methylation capacity in the plasma and aorta, indirectly assessed by the ratio of S-adenosylmethionine to S-adenosylhomocysteine (SAM:SAH) was detected in HHD mice together with a 172-fold increase in aortic cystathionine levels, indicating increased flux through the transsulfuration pathway. Betaine and its metabolic precursor, choline, were significantly decreased in the livers of HHD mice versus CD mice. Widespread changes in the plasma metabolome of HHD mice versus CD animals were detected, including alterations in acylcarnitines, amino acids, bile acids, ceramides, sphingomyelins, triacylglycerol levels, and several indicators of dysfunctional lipid metabolism. This study confirms the relevance of severe HHcy in the progression of vascular plaque and suggests novel metabolic pathways implicated in the pathophysiology of atherosclerosis. FAU - Andrews, Stephen G AU - Andrews SG AD - Department of Nutritional Sciences, Penn State University, University Park, PA 16802, USA. FAU - Koehle, Anthony M AU - Koehle AM AD - Department of Nutritional Sciences, Penn State University, University Park, PA 16802, USA. FAU - Paudel, Devendra AU - Paudel D AUID- ORCID: 0000-0002-6521-9121 AD - Department of Nutritional Sciences, Penn State University, University Park, PA 16802, USA. FAU - Neuberger, Thomas AU - Neuberger T AUID- ORCID: 0000-0002-3965-9780 AD - Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802, USA. AD - Department of Biomedical Engineering, Penn State University, University Park, PA 16802, USA. FAU - Ross, A Catharine AU - Ross AC AUID- ORCID: 0000-0002-6180-9570 AD - Department of Nutritional Sciences, Penn State University, University Park, PA 16802, USA. FAU - Singh, Vishal AU - Singh V AUID- ORCID: 0000-0003-3577-1713 AD - Department of Nutritional Sciences, Penn State University, University Park, PA 16802, USA. FAU - Bottiglieri, Teodoro AU - Bottiglieri T AUID- ORCID: 0000-0002-4199-7551 AD - Center of Metabolomics, Institute of Metabolic Disease, Baylor Scott and White Research Institute, Dallas, TX 75204, USA. FAU - Castro, Rita AU - Castro R AUID- ORCID: 0000-0002-4585-0741 AD - Department of Nutritional Sciences, Penn State University, University Park, PA 16802, USA. AD - Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. LA - eng PT - Journal Article DEP - 20240123 PL - Switzerland TA - Nutrients JT - Nutrients JID - 101521595 RN - 7LP2MPO46S (S-Adenosylmethionine) RN - 935E97BOY8 (Folic Acid) RN - 0 (Apolipoproteins E) RN - 0LVT1QZ0BA (Homocysteine) RN - 0 (Apolipoproteins) SB - IM MH - Mice MH - Animals MH - Humans MH - *Hyperhomocysteinemia MH - *Atherosclerosis/metabolism MH - Diet MH - S-Adenosylmethionine/metabolism MH - Folic Acid/adverse effects MH - Apolipoproteins E/genetics/metabolism MH - Metabolome MH - Homocysteine/metabolism MH - Apolipoproteins/metabolism PMC - PMC10856797 OTO - NOTNLM OT - atheroma OT - high-field MRI OT - hypomethylating stress OT - vascular disease COIS- The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2024/02/10 10:52 MHDA- 2024/02/10 10:53 PMCR- 2024/01/23 CRDT- 2024/02/10 01:04 PHST- 2023/12/03 00:00 [received] PHST- 2023/12/30 00:00 [revised] PHST- 2024/01/09 00:00 [accepted] PHST- 2024/02/10 10:53 [medline] PHST- 2024/02/10 10:52 [pubmed] PHST- 2024/02/10 01:04 [entrez] PHST- 2024/01/23 00:00 [pmc-release] AID - nu16030330 [pii] AID - nutrients-16-00330 [pii] AID - 10.3390/nu16030330 [doi] PST - epublish SO - Nutrients. 2024 Jan 23;16(3):330. doi: 10.3390/nu16030330.